Paper40022166
Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma.
Mi J and 6 others. J Transl Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma. Papers, record 40022166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40022166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuronal guanine nucleotide exchange factor promotes the axonal growth and cancer cell proliferation via Ephrin-A3/EphA2 axis in lung adenocarcinoma.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma of Lung | Major topic |
| Lung Neoplasms | Major topic |
| Axons | Major topic |
| Guanine Nucleotide Exchange Factors | Major topic |
| Nerve Tissue Proteins | Major topic |
| Humans | |
| Cell Proliferation | |
| Animals | |
| Cell Line, Tumor | |
| Signal Transduction | |
| Gene Expression Regulation, Neoplastic | |
| Female | |
| Prognosis | |
| Male | |
| Mice | |
| Mice, Nude |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23YF1435500 | Shanghai Science and Technology Innovation Action Plan | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35227773 | Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. | J Hepatol | 2022 | https://conductscience.org/library/papers/35227773 | PubMed |
| 2 | 29363583 | Ephexin1 Is Required for Eph-Mediated Limb Trajectory of Spinal Motor Axons. | J Neurosci | 2018 | https://conductscience.org/library/papers/29363583 | PubMed |
| 3 | 37980488 | Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression. | J Transl Med | 2023 | https://conductscience.org/library/papers/37980488 | PubMed |
| 4 | 33433946 | Cancer Statistics, 2021. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33433946 | PubMed |
| 5 | 34708571 | Implantable Electrical Stimulation at Dorsal Root Ganglions Accelerates Osteoporotic Fracture Healing via Calcitonin Gene-Related Peptide. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/34708571 | PubMed |
| 6 | 27989802 | Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. | Cancer Cell | 2017 | https://conductscience.org/library/papers/27989802 | PubMed |
| 7 | 29456630 | Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29456630 | PubMed |
| 8 | 32375579 | Calcitonin Gene-Related Peptide Enhances Distraction Osteogenesis by Increasing Angiogenesis. | Tissue Eng Part A | 2021 | https://conductscience.org/library/papers/32375579 | PubMed |
| 9 | 24030979 | Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. | Cancer Res | 2013 | https://conductscience.org/library/papers/24030979 | PubMed |
| 10 | 23846904 | Autonomic nerve development contributes to prostate cancer progression. | Science | 2013 | https://conductscience.org/library/papers/23846904 | PubMed |
| 11 | 38764064 | NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38764064 | PubMed |
| 12 | 34969767 | Nerve Growth Factor in Breast Cancer Cells Promotes Axonal Growth and Expression of Calcitonin Gene-related Peptide in a Rat Model of Spinal Metastasis. | Anticancer Res | 2022 | https://conductscience.org/library/papers/34969767 | PubMed |
| 13 | 32302564 | Roadmap for the Emerging Field of Cancer Neuroscience. | Cell | 2020 | https://conductscience.org/library/papers/32302564 | PubMed |
| 14 | 33288884 | Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. | Oncogene | 2021 | https://conductscience.org/library/papers/33288884 | PubMed |
| 15 | 35627236 | A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35627236 | PubMed |
| 16 | 30682817 | Emerging Roles of Ephexins in Physiology and Disease. | Cells | 2019 | https://conductscience.org/library/papers/30682817 | PubMed |
| 17 | 32473645 | LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32473645 | PubMed |
| 18 | 35941690 | Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35941690 | PubMed |
| 19 | 19361476 | Dehydroepiandrosterone and neurotrophins favor axonal growth in a sensory neuron-keratinocyte coculture model. | Neuroscience | 2009 | https://conductscience.org/library/papers/19361476 | PubMed |
| 20 | 38778601 | Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm. | Curr Gene Ther | 2025 | https://conductscience.org/library/papers/38778601 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41361459 | KIF4A in disease pathogenesis and therapeutics: from molecular mechanisms to clinical translation. | Biol Direct | 2025 | https://conductscience.org/library/papers/41361459 | PubMed |
| 41178927 | Neuro-tumor interactions: Multi-dimensional mechanisms of neurotransmitter regulation in tumor immune evasion and metabolic reprogramming. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/41178927 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EFNA3 | 1944 | PubTator's text mining | https://conductscience.org/library/genes/1944 | NCBI Gene |
| EPHA2 | 1969 | PubTator's text mining | https://conductscience.org/library/genes/1969 | NCBI Gene |
| KIF4A | 24137 | PubTator's text mining | https://conductscience.org/library/genes/24137 | NCBI Gene |
| NGEF | 25791 | PubTator's text mining | https://conductscience.org/library/genes/25791 | NCBI Gene |
| PABPC1 | 26986 | PubTator's text mining | https://conductscience.org/library/genes/26986 | NCBI Gene |
| UCHL1 | 7345 | PubTator's text mining | https://conductscience.org/library/genes/7345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40022166
GET https://conductscience.org/api/papers/v1/40022166/references?page=2